Insulin aspart - A review of its use in the management of type 1 and 2 diabetes mellitus (vol 62, pg 1945, 2002)

被引:0
作者
Chapman, TM
Noble, S
Goa, KL
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:512 / 512
页数:1
相关论文
共 50 条
[41]   Pharmacoeconomic evaluation of insulin aspart and glargine in type 1 and 2 diabetes mellitus in Iran [J].
Nosrati, Marzieh ;
Fariman, Soroush Ahmadi ;
Saiyarsarai, Parisa ;
Nikfar, Shekoufeh .
JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (01) :817-825
[42]   Erratum to: Linagliptin: a review of its use in the management of type 2 diabetes mellitus (vol 72, pg 1793-1824 2012) [J].
Deeks, Emma D. .
DRUGS, 2013, 73 (01) :99-99
[43]   Pharmacoeconomic evaluation of insulin aspart and glargine in type 1 and 2 diabetes mellitus in Iran [J].
Marzieh Nosrati ;
Soroush Ahmadi Fariman ;
Parisa Saiyarsarai ;
Shekoufeh Nikfar .
Journal of Diabetes & Metabolic Disorders, 2023, 22 :817-825
[44]   Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus [J].
Velasquez-Mieyer, Pedro A. ;
Neira, Claudia P. .
EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (13) :2377-2382
[45]   Pioglitazone: A review of its use in type 2 diabetes mellitus. (vol 66, pg 86, 2006) [J].
Waugh, J ;
Keating, GM ;
Plosker, GL ;
Easthope, S ;
Robinson, DM .
DRUGS, 2006, 66 (03) :340-341
[46]   Empagliflozin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus (vol 74, pg 1769, 2014) [J].
Scott, Lesley J. .
DRUGS, 2015, 75 (01) :141-141
[47]   Biphasic insulin aspart in type 2 diabetes mellitus - An evidence-based medicine review [J].
Gough, S. C. L. ;
Tibaldi, J. .
CLINICAL DRUG INVESTIGATION, 2007, 27 (05) :299-324
[48]   Erratum to: Alogliptin: a review of its use in the management of type 2 diabetes mellitus [J].
L. J. Scott .
Drugs, 2010, 70 (18) :2475-2475
[49]   Erratum to: Linagliptin: a review of its use in the management of type 2 diabetes mellitus [J].
Emma D. Deeks .
Drugs, 2013, 73 :99-99
[50]   Insulin GlargineAn Updated Review of its Use in the Management of Diabetes Mellitus [J].
Christopher J. Dunn ;
Greg L. Plosker ;
Gillian M. Keating ;
Kate McKeage ;
Lesley J. Scott .
Drugs, 2003, 63 :1743-1778